Short answer
Boston Scientific (BSX) filed an 8-K current report with the SEC on October 7, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Joe Fitzgerald promoted to COO effective January 1, 2027, expanding oversight from Cardiovascular to companywide operations.
Boston Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Joe Fitzgerald promoted to COO effective January 1, 2027, expanding oversight from Cardiovascular to companywide operations
- COO compensation: $1,050,000 base salary, 110% annual bonus target, and $7,000,000 2027 equity award
- Equity award includes options and RSUs, including performance-based RSUs, vesting 25% annually
- Mark Bickel appointed Chief Accounting Officer effective March 1, 2027, succeeding Emily Woodworth
- Woodworth’s transition is not related to disagreements over financial statements, controls, operations, policies, or practices
Item 8.01 · Other Events
- Exhibit 99.1 contains Boston Scientific’s October 7, 2026 press release
- Announcement concerns the officer or director changes described under Item 5.02
- Investor focus: leadership transition, succession implications and any disclosed compensation terms
Item EX-99.1 · Exhibit EX-99.1
- Joseph M. Fitzgerald named executive vice president and COO effective January 1, 2027
- COO will oversee global operations, business units and regions, creating a significant execution responsibility
- Three reportable segments begin January 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg
- New structure targets faster decisions and strategic investment allocation, but adds execution and integration risk
- Interventional Therapies expected to include Penumbra after anticipated acquisition closing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Boston Scientific 8-K filings
Get the next BSX 8-K as it lands
Follow BSX for push alerts, or ask the research agent what this filing means.